Back |
home / stock / vblt / vblt message board
Subject | By | Source | When |
---|---|---|---|
2.5300+0.1900 (+8.12%) | midastouch017 | investorshub | 09/02/2021 4:20:18 PM |
VBL Therapeutics jumps 12% after resuming U.S. enrollment | midastouch017 | investorshub | 08/30/2021 12:08:33 PM |
VBL Therapeutics Resumes U.S. Enrollment in OVAL Phase | midastouch017 | investorshub | 08/30/2021 11:59:24 AM |
I gathered all the data I have and | Oren1976 | investorshub | 08/28/2021 3:27:34 PM |
Vascular Biogenics Ltd ($VBLT) CEO Dror Harats on | midastouch017 | investorshub | 08/16/2021 3:12:35 PM |
VBL Therapeutics Reports Second Quarter 2021 Financial Results | midastouch017 | investorshub | 08/16/2021 11:30:38 AM |
VBL Therapeutics Q2 2021 Earnings Preview | midastouch017 | investorshub | 08/15/2021 1:01:29 PM |
Vascular Biogenics Ltd. (NASDAQ:VBLT) Expected to Announce Quarterly | midastouch017 | investorshub | 08/15/2021 12:26:22 PM |
News, Short Squeeze, Breakout and More Instantly...
Vascular Biogenics Ltd. Company Name:
VBLT Stock Symbol:
NASDAQ Market:
Approved Merger with Notable Labs and All Other Proposals Merger Expected to Close and Begin Trading as Combined Company Under the NTBL Ticker on Nasdaq Next Week, Subject to Effectiveness of Approved Israeli Corporate Actions MODI’IN, Israel and NEW YORK, Oct. 12, 2023 (GL...
MODI’IN, Israel and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) (“VBL”), reminds its shareholders to vote in favor of the previously announced proposed merger (the “Merger”) with Notable Labs (“Notable”) at the annua...
Merger with Notable expected to close in mid-October, subject to shareholder approval Special shareholder meeting scheduled for October 12, 2023 MODI’IN, Israel and NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) (“VBL”), today ann...